According to Sangamo Therapeutics 's latest financial reports the company's current EPS (TTM) is -1,34ย โฌ. In 2022 the company made an earnings per share (EPS) of -1,16ย โฌ a decrease over its 2021 EPS that were of -1,15ย โฌ.